SMX Security Matters plc vs Sanofi SA — how do they compare? SMX Security Matters plc trades at $19.04 (market cap $16.38M), while Sanofi SA trades at $44.05 (market cap $104.83B). The key difference: Sanofi SA is far larger — about 6399.9× SMX Security Matters plc's market cap, and Sanofi SA pays a 5.5% dividend while SMX Security Matters plc pays none. Which is the better fit depends on your goals.
| SMX | SNY | |
|---|---|---|
Market Cap | $16.38M | $104.83B |
Sector | Technology | Health |
52-Week High | $295.56K | $52.34 |
52-Week Low | $12.87 | $41.33 |
Enterprise Value | $13.35M | $121.32B |
Dividend Yield | — | 5.5% |
Trailing returns across standard periods
Latest headlines on both assets
SMX Security Matters plc is a digital authentication and tracking technology company that uses a chemical-based, invisible marker system to trace and verify products across global supply chains. Their technology creates a 'digital twin' of physical products, used for quality control, counterfeiting prevention, and ensuring sustainability compliance from raw materials to final sale. The company's solutions are applied across various industries, including precious materials, luxury goods, and fast-moving consumer goods.
Read more on SMX →Sanofi develops and markets drugs with a concentration in oncology, immunology, cardiovascular disease, diabetes, and vaccines. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing just over 10% of total sales, but profits are shared with Regeneron. About 30% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.
Read more on SNY →